Lord’s Mark Industries Ltd., a diversified healthcare and technology-led group, announced the acquisition of an 85% stake in Renalyx Health Systems Private Limited, the Bengaluru-based med-tech innovator behind India’s...
NCLT clears Sequent Scientific–Viyash Life Sciences merger worth ₹8,000 crore
Carlyle portfolio companies Sequent Scientific and Viyash Life Sciences received approval for their planned merger from the National Company Law Tribunal (NCLT) on Tuesday, according to sources in the know. Sequent...
Biocon considers merging Biocon Biologics in $4.5 billion deal; IPO and share swap options under review
Biocon Ltd is exploring the merger of its biosimilars arm Biocon Biologics Ltd with itself, people aware of the development told ET. The potential deal is said to value the arm at around $4.5 billion, they said. The...
CSL delays spin-off, cuts profit outlook as US vaccination rates slide
Australian biotech CSL has cut its profit outlook and delayed plans to spin off its vaccine division, blaming an unprecedented fall in U.S. flu immunisation rates, which knocked its shares down as much as 16.6% to a...
Novo Holdings in talks to buy into Surya Hospitals
Novo Holdings, a 142 billion euro investment firm that controls drug maker Novo Nordisk, has entered into exclusive talks to acquire a 49% stake in Mumbai-based Surya Hospitals, said people familiar with the matter. A...
GTCR to Acquire Zentiva in $4.8 Billion Deal
Private equity firm GTCR has agreed to acquire Czech generic drugmaker Zentiva from Advent International in a transaction valued at €4.1 billion ($4.8 billion), according to reports in the Financial Times. The deal...
Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on...
Novartis weighs deal for biotech Avidity Biosciences, FT reports
Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported on Wednesday, citing people familiar with the matter. Shares of Avidity rose 23% to...
France’s Sanofi to acquire biotech firm Vicebio for $1.15 billion
French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1.15 billion, expanding its respiratory vaccine portfolio. Following the acquisition...
Abu Dhabi Investment Authority to buy 3% stake in Micro Life Sciences for $200 mn
Abu Dhabi Investment Authority on Monday said it will acquire a 3 per cent stake in medical devices firm Micro Life Sciences Pvt Ltd (Meril) for USD 200 million. A wholly-owned subsidiary of Abu Dhabi Investment...
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments. Under the deal...
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familiar with the matter...
